Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Enterprise value to sales ratio
3Y CAGR
-26.9%/yr
vs +3.0%/yr prior
5Y CAGR
+1.8%/yr
Recent deceleration
Acceleration
-29.9pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.85 | +10.4% |
| 2024 | 2.58 | -60.8% |
| 2023 | 6.59 | -9.5% |
| 2022 | 7.29 | +191.9% |
| 2021 | 2.50 | -4.5% |
| 2020 | 2.61 | -73.3% |
| 2019 | 9.78 | +51.1% |
| 2018 | 6.47 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |